AGI Greenpac Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: December 11, 2025, 2:34 am

Competitors of AGI Greenpac Ltd

All Competitor Stocks of AGI Greenpac Ltd

Quarterly Result

Last Updated: August 1, 2025, 8:20 am

Below is a detailed analysis of the quarterly data for AGI Greenpac Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 688.00 Cr.. The value appears to be declining and may need further review. It has decreased from 705.00 Cr. (Mar 2025) to 688.00 Cr., marking a decrease of 17.00 Cr..
• For Expenses, as of Jun 2025, the value is 546.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 551.00 Cr. (Mar 2025) to 546.00 Cr., marking a decrease of 5.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 142.00 Cr.. The value appears to be declining and may need further review. It has decreased from 154.00 Cr. (Mar 2025) to 142.00 Cr., marking a decrease of 12.00 Cr..
• For OPM %, as of Jun 2025, the value is 21.00%. The value appears to be declining and may need further review. It has decreased from 22.00% (Mar 2025) to 21.00%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 34.00 Cr.. The value appears to be declining and may need further review. It has decreased from 37.00 Cr. (Mar 2025) to 34.00 Cr., marking a decrease of 3.00 Cr..
• For Interest, as of Jun 2025, the value is 17.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 21.00 Cr. (Mar 2025) to 17.00 Cr., marking a decrease of 4.00 Cr..
• For Depreciation, as of Jun 2025, the value is 41.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 44.00 Cr. (Mar 2025) to 41.00 Cr., marking a decrease of 3.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 118.00 Cr.. The value appears to be declining and may need further review. It has decreased from 126.00 Cr. (Mar 2025) to 118.00 Cr., marking a decrease of 8.00 Cr..
• For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 23.00% (Mar 2025) to 25.00%, marking an increase of 2.00%.
• For Net Profit, as of Jun 2025, the value is 89.00 Cr.. The value appears to be declining and may need further review. It has decreased from 97.00 Cr. (Mar 2025) to 89.00 Cr., marking a decrease of 8.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 13.73. The value appears to be declining and may need further review. It has decreased from 14.93 (Mar 2025) to 13.73, marking a decrease of 1.20.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:01 am

Growth

Last Updated: September 5, 2025, 2:06 pm

Balance Sheet

Last Updated: December 4, 2025, 2:18 am

Below is a detailed analysis of the balance sheet data for AGI Greenpac Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00 Cr..
• For Reserves, as of Sep 2025, the value is 2,204.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,085.00 Cr. (Mar 2025) to 2,204.00 Cr., marking an increase of 119.00 Cr..
• For Borrowings, as of Sep 2025, the value is 460.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 553.00 Cr. (Mar 2025) to 460.00 Cr., marking a decrease of 93.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 687.00 Cr.. The value appears to be improving (decreasing). It has decreased from 846.00 Cr. (Mar 2025) to 687.00 Cr., marking a decrease of 159.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 3,364.00 Cr.. The value appears to be improving (decreasing). It has decreased from 3,496.00 Cr. (Mar 2025) to 3,364.00 Cr., marking a decrease of 132.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 2,032.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2,032.00 Cr..
• For CWIP, as of Sep 2025, the value is 101.00 Cr.. The value appears to be declining and may need further review. It has decreased from 103.00 Cr. (Mar 2025) to 101.00 Cr., marking a decrease of 2.00 Cr..
• For Investments, as of Sep 2025, the value is 10.00 Cr.. The value appears to be declining and may need further review. It has decreased from 35.00 Cr. (Mar 2025) to 10.00 Cr., marking a decrease of 25.00 Cr..
• For Other Assets, as of Sep 2025, the value is 1,220.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,325.00 Cr. (Mar 2025) to 1,220.00 Cr., marking a decrease of 105.00 Cr..
• For Total Assets, as of Sep 2025, the value is 3,364.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,496.00 Cr. (Mar 2025) to 3,364.00 Cr., marking a decrease of 132.00 Cr..

Notably, the Reserves (2,204.00 Cr.) exceed the Borrowings (460.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for AGI Greenpac Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 19) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 49.83. This value is within the healthy range. It has increased from 9.69 (Mar 19) to 49.83, marking an increase of 40.14.
• For Diluted EPS (Rs.), as of Mar 25, the value is 49.83. This value is within the healthy range. It has increased from 9.69 (Mar 19) to 49.83, marking an increase of 40.14.
• For Cash EPS (Rs.), as of Mar 25, the value is 77.22. This value is within the healthy range. It has increased from 30.57 (Mar 19) to 77.22, marking an increase of 46.65.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 324.23. It has increased from 209.25 (Mar 19) to 324.23, marking an increase of 114.98.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 324.23. It has increased from 209.25 (Mar 19) to 324.23, marking an increase of 114.98.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 390.86. It has increased from 375.16 (Mar 19) to 390.86, marking an increase of 15.70.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 106.44. This value is within the healthy range. It has increased from 47.84 (Mar 19) to 106.44, marking an increase of 58.60.
• For PBIT / Share (Rs.), as of Mar 25, the value is 79.05. This value is within the healthy range. It has increased from 26.95 (Mar 19) to 79.05, marking an increase of 52.10.
• For PBT / Share (Rs.), as of Mar 25, the value is 65.97. This value is within the healthy range. It has increased from 14.83 (Mar 19) to 65.97, marking an increase of 51.14.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 49.83. This value is within the healthy range. It has increased from 9.69 (Mar 19) to 49.83, marking an increase of 40.14.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 49.83. This value is within the healthy range. It has increased from 9.69 (Mar 19) to 49.83, marking an increase of 40.14.
• For PBDIT Margin (%), as of Mar 25, the value is 27.23. This value is within the healthy range. It has increased from 12.75 (Mar 19) to 27.23, marking an increase of 14.48.
• For PBIT Margin (%), as of Mar 25, the value is 20.22. This value exceeds the healthy maximum of 20. It has increased from 7.18 (Mar 19) to 20.22, marking an increase of 13.04.
• For PBT Margin (%), as of Mar 25, the value is 16.87. This value is within the healthy range. It has increased from 3.95 (Mar 19) to 16.87, marking an increase of 12.92.
• For Net Profit Margin (%), as of Mar 25, the value is 12.74. This value exceeds the healthy maximum of 10. It has increased from 2.58 (Mar 19) to 12.74, marking an increase of 10.16.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.74. This value is within the healthy range. It has increased from 2.58 (Mar 19) to 12.74, marking an increase of 10.16.
• For Return on Networth / Equity (%), as of Mar 25, the value is 15.36. This value is within the healthy range. It has increased from 4.63 (Mar 19) to 15.36, marking an increase of 10.73.
• For Return on Capital Employeed (%), as of Mar 25, the value is 18.57. This value is within the healthy range. It has increased from 7.66 (Mar 19) to 18.57, marking an increase of 10.91.
• For Return On Assets (%), as of Mar 25, the value is 9.22. This value is within the healthy range. It has increased from 1.96 (Mar 19) to 9.22, marking an increase of 7.26.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 0.2. It has decreased from 0.49 (Mar 19) to 0.18, marking a decrease of 0.31.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.26. This value is within the healthy range. It has decreased from 0.76 (Mar 19) to 0.26, marking a decrease of 0.50.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.00. It has decreased from 0.77 (Mar 19) to 0.00, marking a decrease of 0.77.
• For Current Ratio (X), as of Mar 25, the value is 1.71. This value is within the healthy range. It has increased from 1.33 (Mar 19) to 1.71, marking an increase of 0.38.
• For Quick Ratio (X), as of Mar 25, the value is 1.17. This value is within the healthy range. It has increased from 0.77 (Mar 19) to 1.17, marking an increase of 0.40.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. It has decreased from 1.09 (Mar 19) to 0.00, marking a decrease of 1.09.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 12.04. This value is below the healthy minimum of 20. It has decreased from 49.77 (Mar 19) to 12.04, marking a decrease of 37.73.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 7.77. This value is below the healthy minimum of 20. It has decreased from 15.77 (Mar 19) to 7.77, marking a decrease of 8.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 87.96. This value exceeds the healthy maximum of 70. It has increased from 50.23 (Mar 19) to 87.96, marking an increase of 37.73.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 92.23. This value exceeds the healthy maximum of 70. It has increased from 84.23 (Mar 19) to 92.23, marking an increase of 8.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 8.13. This value is within the healthy range. It has increased from 3.95 (Mar 19) to 8.13, marking an increase of 4.18.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.81. This value is within the healthy range. It has increased from 1.80 (Mar 19) to 4.81, marking an increase of 3.01.
• For Enterprise Value (Cr.), as of Mar 25, the value is 5,009.88. It has increased from 2,903.75 (Mar 19) to 5,009.88, marking an increase of 2,106.13.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.98. This value is within the healthy range. It has increased from 1.07 (Mar 19) to 1.98, marking an increase of 0.91.
• For EV / EBITDA (X), as of Mar 25, the value is 7.27. This value is within the healthy range. It has decreased from 8.40 (Mar 19) to 7.27, marking a decrease of 1.13.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.91. This value is within the healthy range. It has increased from 0.66 (Mar 19) to 1.91, marking an increase of 1.25.
• For Retention Ratios (%), as of Mar 25, the value is 87.95. This value exceeds the healthy maximum of 70. It has increased from 50.22 (Mar 19) to 87.95, marking an increase of 37.73.
• For Price / BV (X), as of Mar 25, the value is 2.30. This value is within the healthy range. It has increased from 1.19 (Mar 19) to 2.30, marking an increase of 1.11.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.91. This value is within the healthy range. It has increased from 0.66 (Mar 19) to 1.91, marking an increase of 1.25.
• For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 19) to 0.06, marking an increase of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness